Solid Biosciences Inc. (SLDB) stock
SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.35+0.12 (+1.93%)
Close on Nov 18, 2026Market cap $680.88MP/E –Yield –
Solid Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Solid Biosciences's price to sales ratio was 23.7× on Feb 29, 2024, against 8.1× a year earlier. Over the last 2 years it ranged from 3.0× to 23.7×, with a median of 7.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Feb 29, 2024 | 23.7× | +8.4 |
| 2023 | Dec 29, 2023 | 15.2× | +12.2 |
| 2022 | Dec 30, 2022 | 3.0× | – |
See a number that looks wrong?